Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs

被引:12
作者
Grimshaw, Ceilidh [1 ]
Boyd, Lynsey [1 ]
Smith, Matt [2 ]
Estcourt, Claudia S. [2 ]
Metcalfe, Rebecca [1 ]
机构
[1] NHS Greater Glasgow & Clyde, Sandyford Initiat, 6 Sandyford Pl, Glasgow G3 7NB, Lanark, Scotland
[2] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland
基金
美国国家卫生研究院;
关键词
adherence; people who inject drugs; pre-exposure prophylaxis; service; uptake; ANTIRETROVIRAL PROPHYLAXIS;
D O I
10.1111/hiv.13181
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives HIV prevention strategies including pre-exposure prophylaxis (PrEP) must reach all in need to achieve elimination of transmission by 2030. Mainstream provision may inadvertently exclude key populations. Incidence of HIV in people who inject drugs (PWID) in Glasgow, Scotland's largest city, is increasing, partly due to sexual transmission. Scotland provides publicly funded oral PrEP for individuals at sexual risk of HIV through sexual health services; however, uptake by PWID has been negligible. We developed a tailored outreach PrEP service based in the local homeless health centre. We used active case finding, flexibility of assessment location, supervised community daily dispensing and active follow-up to optimise uptake and adherence. We describe a two-year service evaluation. Methods We reviewed the case records of all PWID identified by the outreach team as being at higher risk of sexual acquisition for whom PrEP was considered between November 2018 and November 2020. Evaluation focused on PrEP uptake, adherence and monitoring. We conducted a descriptive statistical analysis. Results Of 41 PWID assessed as eligible, 32 (78.0%) commenced PrEP. The proportion of PrEP-covered days was 3320/3400 days (97.6%); 31/32 (96.9%) had regular HIV serology monitoring. The service was feasible to run, but it relied on outreach provision and liaison with other services. Discussion Tailored PrEP services can reach PWID effectively. Uptake and adherence were high but the model was resource-intensive. Appropriately tailored PrEP delivery may be required to meet the needs of this and other key populations who experience barriers to accessing mainstream services.
引用
收藏
页码:965 / 970
页数:6
相关论文
共 21 条
[1]  
[Anonymous], COST EFFECTIVENESS A
[2]  
[Anonymous], 2015, PEOPL WHO INJ DRUGS
[3]  
[Anonymous], WILL US PRE EXP PROP
[4]  
[Anonymous], 2016, Fast-Track Commitments to End AIDS by 2030
[5]   Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women [J].
Baeten, J. M. ;
Donnell, D. ;
Ndase, P. ;
Mugo, N. R. ;
Campbell, J. D. ;
Wangisi, J. ;
Tappero, J. W. ;
Bukusi, E. A. ;
Cohen, C. R. ;
Katabira, E. ;
Ronald, A. ;
Tumwesigye, E. ;
Were, E. ;
Fife, K. H. ;
Kiarie, J. ;
Farquhar, C. ;
John-Stewart, G. ;
Kakia, A. ;
Odoyo, J. ;
Mucunguzi, A. ;
Nakku-Joloba, E. ;
Twesigye, R. ;
Ngure, K. ;
Apaka, C. ;
Tamooh, H. ;
Gabona, F. ;
Mujugira, A. ;
Panteleeff, D. ;
Thomas, K. K. ;
Kidoguchi, L. ;
Krows, M. ;
Revall, J. ;
Morrison, S. ;
Haugen, H. ;
Emmanuel-Ogier, M. ;
Ondrejcek, L. ;
Coombs, R. W. ;
Frenkel, L. ;
Hendrix, C. ;
Bumpus, N. N. ;
Bangsberg, D. ;
Haberer, J. E. ;
Stevens, W. S. ;
Lingappa, J. R. ;
Celum, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05) :399-410
[6]   Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions [J].
Bazzi, Angela R. ;
Drainoni, Mari-Lynn ;
Biancarelli, Dea L. ;
Hartman, Joshua J. ;
Mimiaga, Matthew J. ;
Mayer, Kenneth H. ;
Biello, Katie B. .
BMC PUBLIC HEALTH, 2019, 19 (1)
[7]   Delivering Preexposure Prophylaxis to People Who Use Drugs and Experience Homelessness, Boston, MA, 2018-2020 [J].
Biello, Katie B. ;
Bazzi, Angela R. ;
Vahey, Seamus ;
Harris, Mary ;
Shaw, Leah ;
Brody, Jennifer .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2021, 111 (06) :1045-1048
[8]   Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial [J].
Choopanya, Kachit ;
Martin, Michael ;
Suntharasamai, Pravan ;
Sangkum, Udomsak ;
Mock, Philip A. ;
Leethochawalit, Manoj ;
Chiamwongpaet, Sithisat ;
Kitisin, Praphan ;
Natrujirote, Pitinan ;
Kittimunkong, Somyot ;
Chuachoowong, Rutt ;
Gvetadze, Roman J. ;
McNicholl, Janet M. ;
Paxton, Lynn A. ;
Curlin, Marcel E. ;
Hendrix, Craig W. ;
Vanichseni, Suphak .
LANCET, 2013, 381 (9883) :2083-2090
[9]  
Estcourt C., 2021, AIDS
[10]   Implementation of a national HIV pre-exposure prophylaxis service is associated with changes in characteristics of people with newly diagnosed HIV: a retrospective cohort study [J].
Grimshaw, Ceilidh ;
Estcourt, Claudia S. ;
Nandwani, Rak ;
Yeung, Alan ;
Henderson, David ;
Saunders, John Michael .
SEXUALLY TRANSMITTED INFECTIONS, 2022, 98 (01) :53-57